Kovack Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $719K | Buy |
1,410
+6
| +0.4% | +$2.88K | 0.03% | 490 |
|
|
2026
Q1 | $694K | Sell |
1,404
-111
| -7% | -$60.2K | 0.04% | 493 |
|
|
2025
Q4 | $878K | Buy |
1,515
+276
| +22% | +$156K | 0.04% | 426 |
|
|
2025
Q3 | $601K | Sell |
1,239
-60
| -5% | -$27.9K | 0.06% | 287 |
|
|
2025
Q2 | $527K | Sell |
1,299
-149
| -10% | -$62.3K | 0.05% | 313 |
|
|
2025
Q1 | $720K | Buy |
1,448
+4
| +0.3% | +$2.17K | 0.08% | 225 |
|
|
2024
Q4 | $751K | Buy |
1,444
+92
| +7% | +$50.6K | 0.07% | 222 |
|
|
2024
Q3 | $837K | Sell |
1,352
-99
| -7% | -$58.6K | 0.09% | 188 |
|
|
2024
Q2 | $802K | Sell |
1,451
-596
| -29% | -$341K | 0.09% | 202 |
|
|
2024
Q1 | $1.19M | Sell |
2,047
-258
| -11% | -$145K | 0.14% | 131 |
|
|
2023
Q4 | $1.22M | Sell |
2,305
-9
| -0.4% | -$4.36K | 0.15% | 143 |
|
|
2023
Q3 | $1.17M | Sell |
2,314
-123
| -5% | -$65.5K | 0.16% | 132 |
|
|
2023
Q2 | $1.27M | Buy |
2,437
+15
| +0.6% | +$8.09K | 0.16% | 131 |
|
|
2023
Q1 | $1.4M | Sell |
2,422
-111
| -4% | -$62.6K | 0.19% | 123 |
|
|
2022
Q4 | $1.39M | Buy |
2,533
+719
| +40% | +$381K | 0.2% | 111 |
|
|
2022
Q3 | $920K | Sell |
1,814
-17
| -0.9% | -$9.51K | 0.14% | 163 |
|
|
2022
Q2 | $995K | Sell |
1,831
-119
| -6% | -$65.5K | 0.13% | 166 |
|
|
2022
Q1 | $1.15M | Sell |
1,950
-564
| -22% | -$324K | 0.12% | 181 |
|
|
2021
Q4 | $1.68M | Sell |
2,514
-51
| -2% | -$31.8K | 0.16% | 145 |
|
|
2021
Q3 | $1.47M | Buy |
2,565
+199
| +8% | +$109K | 0.16% | 156 |
|
|
2021
Q2 | $1.19M | Buy |
2,366
+84
| +4% | +$39.6K | 0.14% | 174 |
|
|
2021
Q1 | $1.04M | Sell |
2,282
-572
| -20% | -$273K | 0.14% | 173 |
|
|
2020
Q4 | $1.33M | Buy |
2,854
+116
| +4% | +$54.4K | 0.19% | 130 |
|
|
2020
Q3 | $1.21M | Sell |
2,738
-221
| -7% | -$91.3K | 0.22% | 122 |
|
|
2020
Q2 | $1.07M | Sell |
2,959
-439
| -13% | -$147K | 0.21% | 119 |
|
|
2020
Q1 | $964K | Buy |
3,398
+464
| +16% | +$146K | 0.22% | 112 |
|
|
2019
Q4 | $953K | Sell |
2,934
-1,252
| -30% | -$380K | 0.17% | 151 |
|
|
2019
Q3 | $1.22M | Buy |
4,186
+443
| +12% | +$127K | 0.25% | 94 |
|
|
2019
Q2 | $1.1M | Buy |
3,743
+1,153
| +45% | +$318K | 0.25% | 100 |
|
|
2019
Q1 | $709K | Buy |
2,590
+32
| +1% | +$7.96K | 0.18% | 144 |
|
|
2018
Q4 | $573K | Buy |
2,558
+696
| +37% | +$163K | 0.17% | 146 |
|
|
2018
Q3 | $455K | Sell |
1,862
-164
| -8% | -$37.7K | 0.12% | 212 |
|
|
2018
Q2 | $420K | Sell |
2,026
-98
| -5% | -$20.8K | 0.12% | 205 |
|
|
2018
Q1 | $439K | Buy |
+2,124
| New | +$446K | 0.11% | 220 |
|
|
2017
Q4 | – | Sell |
-1,795
| Closed | -$340K | – | 500 |
|
|
2017
Q3 | $340K | Buy |
1,795
+26
| +1% | +$4.71K | 0.11% | 217 |
|
|
2017
Q2 | $309K | Buy |
1,769
+201
| +13% | +$33.8K | 0.1% | 245 |
|
|
2017
Q1 | $241K | Sell |
1,568
-1,564
| -50% | -$239K | 0.09% | 233 |
|
|
2016
Q4 | $442K | Buy |
3,132
+1,523
| +95% | +$225K | 0.21% | 116 |
|
|
2016
Q3 | $256K | Buy |
1,609
+48
| +3% | +$7.4K | 0.12% | 186 |
|
|
2016
Q2 | $231K | Buy |
1,561
+144
| +10% | +$21.3K | 0.12% | 203 |
|
|
2016
Q1 | $201K | Sell |
1,417
-20
| -1% | -$2.68K | 0.13% | 204 |
|
|
2015
Q4 | $204K | Buy |
+1,437
| New | +$192K | 0.13% | 186 |
|
|
2015
Q3 | – | Sell |
-1,756
| Closed | -$228K | – | 244 |
|
|
2015
Q2 | $228K | Buy |
1,756
+199
| +13% | +$25.9K | 0.16% | 165 |
|
|
2015
Q1 | $209K | Buy |
+1,557
| New | +$201K | 0.18% | 145 |
|
|
2014
Q4 | – | Sell |
-1,745
| Closed | -$212K | – | 184 |
|
|
2014
Q3 | $212K | Buy |
+1,745
| New | +$212K | 0.31% | 87 |
|
Other funds holding TMO
Kovack Advisors's TMO Position: Q2 2026 in Review
Kovack Advisors increased its Thermo Fisher Scientific (TMO) stake by 0.43% in Q2 2026, buying an estimated $2.88K and bringing the position to 1,410 shares worth $719K. The position accounts for 0.03% of the portfolio, ranked #490.
Kovack Advisors first reported a position in TMO in Q3 2014 and has held it in 45 quarters since. The position peaked at $1.68M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Kovack Advisors held 1,410 shares of Thermo Fisher Scientific worth $719K as of Q2 2026.
- Kovack Advisors bought 6 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.88K.
- Thermo Fisher Scientific made up 0.03% of Kovack Advisors's portfolio in Q2 2026, its #490 holding.
- Kovack Advisors first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 45 quarters since.
- Kovack Advisors's Thermo Fisher Scientific position peaked at $1.68M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.